11 - 15 of 15 Results
Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.
The widespread use of inexpensive salt hydrate-based phase change materials, or PCMs, has been prevented by a key technical challenge: phase separation, also known as incongruency, which results in the significant degradation of the materials' ability to store thermal energy o
An ORNL team has developed a method for screening for an immunoregulatory protein, which includes assessing the sequence of a candidate protein to determine if it is an immunoregulatory protein when at least one plasminogen-apple-nematode (PAN) domain with a consensus sequence